Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Deane

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Trauma Surgery & Acute Care Open|March 23, 2019
Chance to cut: defining a negative exploration rate in patients with suspected necrotizing soft tissue infectionErin C Howell, Jessica A Keeley, Amy H Kaji, et al.
Frontiers in Pharmacology|November 9, 2023
Efficacy of dual intracerebroventricular and intravitreal <i>CLN5</i> gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten diseaseSamantha J Murray, Martin P Wellby, Graham K Barrell, et al.
Brain and Behavior|April 4, 2025
Magnetic Resonance Imaging as a Readout of CLN5 Gene Therapy Efficacy in SheepSamantha J Murray, Mustafa M Almuqbel, Simon A Felton, et al.
Frontiers in Genetics|August 24, 2023
Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten diseaseNadia L Mitchell, Samantha J Murray, Martin P Wellby, et al.
Parasitology|July 4, 2019
Validation of a death assay for <i>Angiostrongylus cantonensis</i> larvae (L3) using propidium iodide in a rat model (<i>Rattus norvegicus</i>)Susan I Jarvi, John Jacob, Robert T Sugihara, et al.
NPJ Parkinson'S Disease|February 13, 2026
Altered cerebrovascular haemodynamics in Parkinson's disease: Insights from 4D flow MRIAshley R Deane, Daniel J Myall, Anna Pilbrow, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Trauma Surgery & Acute Care Open|March 23, 2019
Chance to cut: defining a negative exploration rate in patients with suspected necrotizing soft tissue infectionErin C Howell, Jessica A Keeley, Amy H Kaji, et al.
Frontiers in Pharmacology|November 9, 2023
Efficacy of dual intracerebroventricular and intravitreal <i>CLN5</i> gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten diseaseSamantha J Murray, Martin P Wellby, Graham K Barrell, et al.
Brain and Behavior|April 4, 2025
Magnetic Resonance Imaging as a Readout of CLN5 Gene Therapy Efficacy in SheepSamantha J Murray, Mustafa M Almuqbel, Simon A Felton, et al.
Frontiers in Genetics|August 24, 2023
Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten diseaseNadia L Mitchell, Samantha J Murray, Martin P Wellby, et al.
Parasitology|July 4, 2019
Validation of a death assay for <i>Angiostrongylus cantonensis</i> larvae (L3) using propidium iodide in a rat model (<i>Rattus norvegicus</i>)Susan I Jarvi, John Jacob, Robert T Sugihara, et al.
NPJ Parkinson'S Disease|February 13, 2026
Altered cerebrovascular haemodynamics in Parkinson's disease: Insights from 4D flow MRIAshley R Deane, Daniel J Myall, Anna Pilbrow, et al.
Pageof 8